Balyasny Asset Management Portfolio holdings
AUM
$44B
1-Year Return
17.37%
This Quarter Return
+3.19%
1 Year Return
+17.37%
3 Year Return
+72.12%
5 Year Return
+152.69%
10 Year Return
+378.29%
AUM
$43B
AUM Growth
+$4.1B
(+11%)
Cap. Flow
+$2.87B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
9.74%
Holding
2,539
New
578
Increased
629
Reduced
629
Closed
592
Top Buys
| 1 |
Amazon
AMZN
|
+$702M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$374M |
| 3 |
Coca-Cola
KO
|
+$350M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 5 |
Salesforce
CRM
|
+$344M |
Top Sells
| 1 |
Spotify
SPOT
|
+$328M |
| 2 |
CME Group
CME
|
+$265M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$220M |
| 4 |
Meta Platforms (Facebook)
META
|
+$212M |
| 5 |
Adobe
ADBE
|
+$209M |
Sector Composition
| 1 | Technology | 16.21% |
| 2 | Consumer Discretionary | 14.9% |
| 3 | Financials | 13.06% |
| 4 | Industrials | 12.72% |
| 5 | Healthcare | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Treace Medical Concepts
TMCI
$442M
| $87.2K | ﹤0.01% |
11,723
-189,380
| -94% | -$1.41M |
|
|
CLPR
1802
Clipper Realty
CLPR
$69.8M
| $87K | ﹤0.01% |
+18,995
| New | +$87K |
|
|
PHX
1803
DELISTED
PHX Minerals
PHX
| $85.5K | ﹤0.01% |
+21,387
| New | +$85.5K |
|
1804
KORU Medical Systems
KRMD
$187M
| $84.4K | ﹤0.01% |
+21,924
| New | +$84.4K |
|
1805
Oportun Financial
OPRT
$283M
| $79.5K | ﹤0.01% |
+20,490
| New | +$79.5K |
|
1806
Advantage Solutions
ADV
$600M
| $79.4K | ﹤0.01% |
27,195
-6,006
| -18% | -$17.5K |
|
1807
DiaMedica Therapeutics
DMAC
$369M
| $79.2K | ﹤0.01% |
+14,581
| New | +$79.2K |
|
1808
Lantronix
LTRX
$184M
| $79K | ﹤0.01% |
+19,163
| New | +$79K |
|
1809
Titan International
TWI
$546M
| $73.9K | ﹤0.01% |
+10,886
| New | +$73.9K |
|
1810
Stem
STEM
$111M
| $73.2K | ﹤0.01% |
6,069
+5,163
| +570% | +$62.3K |
|
1811
Butterfly Network
BFLY
$378M
| $71.2K | ﹤0.01% |
+22,825
| New | +$71.2K |
|
|
CKPT
1812
DELISTED
Checkpoint Therapeutics
CKPT
| $64.7K | ﹤0.01% |
+20,221
| New | +$64.7K |
|
|
SRTA
1813
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$326M
| $62.1K | ﹤0.01% |
+14,600
| New | +$62.1K |
|
1814
Babcock & Wilcox
BW
$266M
| $60.2K | ﹤0.01% |
+36,711
| New | +$60.2K |
|
1815
Xeris Biopharma Holdings
XERS
$1.26B
| $58.1K | ﹤0.01% |
+17,153
| New | +$58.1K |
|
|
URG
1816
Ur-Energy
URG
$547M
| $57.1K | ﹤0.01% |
+49,651
| New | +$57.1K |
|
1817
Aldeyra Therapeutics
ALDX
$333M
| $56.3K | ﹤0.01% |
+11,278
| New | +$56.3K |
|
1818
Hertz
HTZ
$1.82B
| $55.2K | ﹤0.01% |
+15,080
| New | +$55.2K |
|
1819
LifeMD
LFMD
$282M
| $51.6K | ﹤0.01% |
+10,423
| New | +$51.6K |
|
1820
Gray Television
GTN
$579M
| $51.2K | ﹤0.01% |
16,243
-21,006
| -56% | -$66.2K |
|
1821
Bit Digital
BTBT
$951M
| $50.4K | ﹤0.01% |
+17,201
| New | +$50.4K |
|
1822
EVgo
EVGO
$515M
| $48.6K | ﹤0.01% |
11,996
-247,492
| -95% | -$1M |
|
|
LFT
1823
Lument Finance Trust
LFT
$122M
| $48.5K | ﹤0.01% |
+18,801
| New | +$48.5K |
|
1824
Prime Medicine
PRME
$693M
| $47.7K | ﹤0.01% |
+16,342
| New | +$47.7K |
|
1825
Lloyds Banking Group
LYG
$66.4B
| $46K | ﹤0.01% |
16,904
-7,847
| -32% | -$21.3K |
|